Supriya Lifescience Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Supriya Lifescience Ltd. on BSE

Search Inside the pdf :

Supriya Lifescience Ltd.

28 Apr 2025

644.50

3.40%

Corp. Note

Supriya Lifescience Ltd - 543434 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySupriya Lifescience Ltd 2CIN NO.L51900MH2008PLC180452 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Prachi Sathe Designation: Company Secretary and Compliance Officer EmailId: cs@supriyalifescience.com Name of the Chief Financial Officer: Krishna Raghunathan Designation: Chief Financial Officer EmailId: cs@supriyalifescience.com Date: 28/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Supriya Lifescience Ltd.

24 Apr 2025

644.50

3.40%

AGM

Supriya Lifescience Ltd - 543434 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

The Scrutinizers'' report & Voting Results for the Postal ballot conducted by the Company is attached herewith.

pdf

Supriya Lifescience Ltd.

24 Apr 2025

644.50

3.40%

AGM

Supriya Lifescience Ltd - 543434 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

BSE India

The Voting Results and Scrutinizers'' Report for the Postal Ballot conducted by the Company is attached herewith.

pdf

Supriya Lifescience Ltd.

15 Apr 2025

644.50

3.40%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Enclosed herewith details of Analyst/Institutional Investor Meeting.

pdf

Supriya Lifescience Ltd.

11 Apr 2025

644.50

3.40%

Company Update

Supriya Lifescience Ltd - 543434 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Company has informed exchanges about certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025.

pdf

Supriya Lifescience Ltd.

01 Apr 2025

644.50

3.40%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Enclosed herewith details of Analyst/Institutional Investor Meetings.

pdf

Supriya Lifescience Ltd.

26 Mar 2025

644.50

3.40%

SAST

Supriya Lifescience Ltd - 543434 - Closure of Trading Window

BSE India

Intimation for closure of Trading Window

pdf

Supriya Lifescience Ltd.

25 Mar 2025

644.50

3.40%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Enclosed herewith Newspaper Publication for Postal Ballot.

pdf

Supriya Lifescience Ltd.

24 Mar 2025

644.50

3.40%

AGM

Supriya Lifescience Ltd - 543434 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

Please find attached Postal Ballot Notice of Supriya Lifesciences Limited

pdf

Supriya Lifescience Ltd.

17 Mar 2025

644.50

3.40%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the details of the Analyst/ Investor Meetings to be attended by the Company are enclosed herewith.

pdf

VOTE: Is Supriya Lifescience Ltd. worth buying?

97 Votes:

Buy 85.57%

Sell 7.22%

Hold 7.22%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf